Let’s start up with the current stock price of Bristol-Myers Squibb Company (BMY), which is $79.14 to be very precise. The Stock rose vividly during the last session to $79.22 after opening rate of $78.60 while the lowest price it went was recorded $78.53 before closing at $78.86.Recently in News on November 21, 2022, Bristol Myers Squibb Data at ASH 2022 Highlight Innovative Therapeutic Platforms Across a Range of Blood Diseases. New data from our multiple myeloma portfolio across targets and molecular approaches show significant progress toward our goal of transforming the treatment paradigm and improving outcomes for patients. You can read further details here
Bristol-Myers Squibb Company had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $81.17 on 11/09/22, with the lowest value was $60.86 for the same time period, recorded on 01/06/22.
Bristol-Myers Squibb Company (BMY) full year performance was 37.75%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bristol-Myers Squibb Company shares are logging -2.50% during the 52-week period from high price, and 48.70% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $53.22 and $81.17.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5699996 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bristol-Myers Squibb Company (BMY) recorded performance in the market was 26.93%, having the revenues showcasing 10.69% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 167.63B, as it employees total of 32200 workers.
Analysts verdict on Bristol-Myers Squibb Company (BMY)
During the last month, 9 analysts gave the Bristol-Myers Squibb Company a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 10 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 73.25, with a change in the price was noted +3.18. In a similar fashion, Bristol-Myers Squibb Company posted a movement of +4.19% for the period of last 100 days, recording 9,450,396 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BMY is recording 1.20 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.13.
Bristol-Myers Squibb Company (BMY): Technical Analysis
Raw Stochastic average of Bristol-Myers Squibb Company in the period of last 50 days is set at 84.19%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 72.19%. In the last 20 days, the company’s Stochastic %K was 73.61% and its Stochastic %D was recorded 69.51%.
Let’s take a glance in the erstwhile performances of Bristol-Myers Squibb Company, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 26.93%. Additionally, trading for the stock in the period of the last six months notably improved by 2.46%, alongside a boost of 37.75% for the period of the last 12 months. The shares increased approximately by 3.93% in the 7-day charts and went down by 8.75% in the period of the last 30 days. Common stock shares were driven by 10.69% during last recorded quarter.